Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zile

Showing results (911-920 of 1,060) with videos related to

Pageof 106
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 10, 2020
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fractionLi Shen, Pardeep S Jhund, Inder S Anand, et al.
Circulation|January 6, 2017
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)Søren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 21, 2023
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failurePaolo Tolomeo, Jawad H Butt, Toru Kondo, et al.
JACC. Heart Failure|December 1, 2022
Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF TrialMichael R Zile, Mandeep R Mehra, Anique Ducharme, et al.
European Heart Journal|April 13, 2023
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trialPaolo Tolomeo, Jawad H Butt, Toru Kondo, et al.
American Heart Journal|June 5, 2017
The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HFUlrik M Mogensen, Lars Køber, Søren L Kristensen, et al.
JACC. Heart Failure|April 16, 2018
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart FailureKevin Damman, Mauro Gori, Brian Claggett, et al.
The American Journal of Medicine|October 3, 2020
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and HypertensionCharles Faselis, Phillip H Lam, Michael R Zile, et al.
Cell|June 25, 2024
Pan-cancer proteogenomics expands the landscape of therapeutic targetsSara R Savage, Xinpei Yi, Jonathan T Lei, et al.
European Journal of Heart Failure|November 22, 2016
Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fractionJane A Cannon, Li Shen, Pardeep S Jhund, et al.
Pageof 106

Showing results (911-920 of 1,060) with videos related to

Sort By:
Pageof 106
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 10, 2020
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fractionLi Shen, Pardeep S Jhund, Inder S Anand, et al.
Circulation|January 6, 2017
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)Søren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 21, 2023
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failurePaolo Tolomeo, Jawad H Butt, Toru Kondo, et al.
JACC. Heart Failure|December 1, 2022
Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF TrialMichael R Zile, Mandeep R Mehra, Anique Ducharme, et al.
European Heart Journal|April 13, 2023
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trialPaolo Tolomeo, Jawad H Butt, Toru Kondo, et al.
American Heart Journal|June 5, 2017
The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HFUlrik M Mogensen, Lars Køber, Søren L Kristensen, et al.
JACC. Heart Failure|April 16, 2018
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart FailureKevin Damman, Mauro Gori, Brian Claggett, et al.
The American Journal of Medicine|October 3, 2020
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and HypertensionCharles Faselis, Phillip H Lam, Michael R Zile, et al.
Cell|June 25, 2024
Pan-cancer proteogenomics expands the landscape of therapeutic targetsSara R Savage, Xinpei Yi, Jonathan T Lei, et al.
European Journal of Heart Failure|November 22, 2016
Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fractionJane A Cannon, Li Shen, Pardeep S Jhund, et al.
Pageof 106